# NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

> **NCT05083260** · PHASE1,PHASE2 · COMPLETED · sponsor: **BioVie Inc.** · enrollment: 46 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** NE3107
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05083260
- **Lead sponsor:** BioVie Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2022-11-21
- **Final completion:** 2023-01-04
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05083260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05083260, "NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05083260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*